Delivery Order SPE2DB22D3016-SPE2DB24FBHQ6
Award Date
9/23/24
Potential Completion Date
10/15/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $35,881.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication, with a completion date of February 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition....
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This federal contract award, valued at $124,028.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22FP0U3) for the supply of DARZALEX FASPRO, a specialty medication, with an ultimate completion date of July 22, 2022. The contract is a firm fixed-price arrangement, and no set-aside designation was used. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML medication. The firm-fixed-price delivery order, valued at $31,007.16, has a completion date of January 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,960.42 firm fixed-price delivery order is for the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a period of performance through July 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $59,802.10. The contract does not have a set-aside designation, indicating open competition. The contract is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a pharmaceutical product, with a period of performance ending on June 12,...
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, provides for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication, to the Defense Logistics Agency (DLA). The $16,561.26 firm-fixed-price delivery order has an ultimate completion date of August 12, 2024. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,802.10 firm fixed-price delivery order contract is for the supply of DARZALEX FASPRO, a pharmaceutical product, with a performance period extending until July 8, 2025. The contract is not set aside and involves open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, valued at $110,408.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO, a specialty medication, and is a Firm Fixed Price Delivery Order that runs through November 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract, valued at $44,163.36, was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 13, 2024, with a completion date of July 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger...